1-100 Flashcards
The most likely diagnosis for a child with fever and ear pain who has a bulging, opaque, erythematous tympanic membrane with impaired mobility is
acute otitis media
Otitis media with effusion (OME) can be defined as
effusion within the middle ear without evidence of infection.
Cholesteatoma is
an accumulation of squamous epithelial cells, usually visible as a discrete white mass behind the TM, which can be congenital or acquired, most commonly
in the setting of chronic otitis media.
A 7-year-old boy presents for a hearing evaluation. His mother reports that for the
past few months, he has been listening to music and television at higher volumes.
His teacher has moved his seat to the front of the classroom because of perceived
hearing difficulties. He had middle- ear infections at ages 2 and 3 years. He has been
in good health since then and does not have any current ear pain, fevers, or upper
respiratory symptoms.
He appears well and is afebrile. His vital signs are within normal limits. The right ear
is examined otoscopically (figure).
The most likely diagnosis in a child who presents with hearing loss and is found
to have a white mass behind an intact eardrum is cholesteatoma.
what is the first line and second line treatment and third line treatment of acute otitis media? most common cause?
The bulging, erythematous appearance of this child’s tympanic membrane
suggests a diagnosis of unilateral AOM.
Streptococcus pneumoniae is the most common bacterial cause.
Intramuscular ceftriaxone can be used to treat recurrent AOM but is not a first-line
therapy because it is a more broad-spectrum antibiotic than amoxicillin, and it is
more challenging to administer. In recurrent AOM, three doses of intramuscular
ceftriaxone have been shown to be superior to one for eradicating penicillinresistant S. pneumoniae from the middle ear.
Amoxicillin–clavulanate is not considered first-line therapy for uncomplicated
AOM. It should be reserved for infections not responding to amoxicillin and can be considered in children with more complicated cases, such as those with multiple
prior infections or AOM with acute tympanic membrane perforation.
Azithromycin is not recommended for treatment of AOM unless the child has a
well-documented amoxicillin allergy.
explain management acute otitis media?
Given that she has had a fever >39°C,
antibiotics are required. First-line therapy consists of a 10-day course of highdose amoxicillin (90 mg/kg/day divided into two doses per day) because
For children older than 6 months who have unilateral AOM, mild symptoms, fever
<39°C, and normal immune systems, a wait-and-see approach to antibiotic
therapy should be discussed with parents as an option. If this approach is
implemented, close follow-up should be arranged for 48 to 72 hours after initial
diagnosis or a prescription for antibiotic therapy should be provided, but
caregivers should initiate therapy only if symptoms persist or worsen (increased
ear pain, temperature >39°C). Children with bilateral disease can be offered
watchful waiting if they are at least 2 years of age, but those younger than 2 years
should be treated.
When sound conducted through air is abnormal but sound conducted through bone is normal, the diagnosis is
conductive hearing loss.
Bilateral otitis media with effusion
leads to
conductive hearing loss by preventing the tympanic membrane from vibrating appropriately and transmitting sound through the ossicles to the cochlea via the oval
window.
Congenital deafness is
usually familial and nearly always sensorineural; connexin 26 mutations are the most common cause.
Vestibular schwannoma can occur in patients with
neurofibromatosis type 2 and would lead to sensorineural hearing loss.
Aminoglycosides, such as gentamicin, are toxic to
cochlear hair cells and can lead to sensorineural hearing loss.
Bacterial meningitis is a common cause of
acquired sensorineural hearing loss.
The most appropriate screening strategy for hearing loss in an infant who passed
her newborn hearing screen but has risk factors for hearing loss is
repeat formal diagnostic audiologic assessment by 24 to 30 months of age.
Otoacoustic emission screening is routinely used to screen
healthy newborns and
is commonly used for office-based hearing screening. It uses a small signal to
stimulate the hairs in the cochlea to obtain a response. However, it is not an
adequate screening test for children with risk factors for hearing loss.
Conventional screening audiometry requires that
the patient be able to reliably
understand and follow instructions; thus, it is not appropriate for children younger
than 4 years of age